Atezolizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Atezolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Atezolizumab but not durvalumab binds and blocks mouse PD-L1.
Efalizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Efalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Epratuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Epratuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Alemtuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Alemtuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Brolucizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Ipilimumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. The research grade Ipilimumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample...
Obinutuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Obinutuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...
Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...
Omalizumab Biosimilar, L234A L235A P329G (LALAPG) Fc Silent Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only...
Palivizumab Biosimilar, N297A Mutant. Palivizumab biosimilar CHO stable cell line is available for licensing to manufacture the palivizumab biosimilar protein. The research grade palivizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1...
